Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 675-681

  Tazzari, Pier Luigi ^a   Cappellini, Alessandra ^b   Grafone, Tiziana ^b   Mantovani, Irina ^b   Ricci, Francesca ^a   Billi, Anna Maria ^b   Ottaviani, Emanuela ^b   Conte, Roberto ^a   Martinelli, Giovanni ^b   Martelli, Alberto M ^b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Acute leukaemia; Flow cytometry; Molecular diagnostics; Prognostic factors; Protein phosphorylation

Indexed keywords

CD33 ANTIGEN; PROTEIN KINASE B; SERINE; THREONINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; WESTERN BLOTTING;

ACUTE DISEASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOID; PHOSPHORYLATION; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SERINE;

EID: 4544224035     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05121.x     Document Type: Article

References (34)

1. Bradbury, D.A., Zhu, Y.M. & Russell, N.H. (1997) Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 expression. Leukemia and Lymphoma, 24, 221-228.
2. Brazil, D.P. & Hemmings, B.A. (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends in Biochemical Sciences, 26, 657-664.
3. Brognard, J., Clark, A.S., Ni, Y. & Dennis, P.A. (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Research, 61, 3986-3997.
4. Cantrell, D.A. (2001) Phosphoinositide 3-kinase signalling pathways. Journal of Cell Science, 114, 1439-1445.
5. Chang, F., Lee, J.T., Navolanic, P.M., Steelman, L.S., Shelton, J.G., Blalock, W.L., Franklin, R.A. & McCubrey, J.A. (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia, 17, 590-603.
6. Crossley, L.J. (2003) Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-l. Journal of Leukocyte Biology, 74, 583-592.
7. Curti, A., Ratta, M., Corinti, S., Girolomoni, G., Ricci, F., Tazzari, P.L., Siena, M., Grande, A., Fogli, M., Tura, S. & Lemoli, R.M. (2001) Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood, 97, 2758-2763.
8. Curti, A., Tafuri, A., Ricciardi, M.R., Tazzari, P.L., Petrucci, M.T., Fogli, M., Ratta, M., Lapalombella, R., Ferri, E., Tura, S., Baccarani, M. & Lemoli, R.M. (2002) Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). Haematologica, 87, 373-380.
9. Freeburn, R.W., Wright, K.L., Burgess, S.J., Astoul, E., Cantrell, D.A. & Ward, S.G. (2002) Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. Journal of Immunology, 169, 5441-5450.
10. Hanada, H., Feng, J. & Hemmings, B.A. (2004) Structure, regulation and function of PKB/Akt-a major therapeutic target. Biochimica et Biophysica Acta, 1697, 3-16.
11. Hill, M.H. & Hemmings, B.A. (2002) Inhibition of protein kinase B/Akt: implications for cancer therapy. Pharmacology and Therapeutics, 93, 243-251.
12. Horiguchi, A., Oya, M., Uchida, A., Marumo, K. & Murai, M. (2003) Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. Journal of Urology, 169, 710-713.
13. Hsu, J., Shi, Y., Krajewski, S., Renner, S., Fisher, M., Reed, J.C., Franke, T.F. & Lichtenstein, A. (2001) The AKT kinase is activated in multiple myeloma tumor cells. Blood, 98, 2853-2855.
14. Hsu, M.J., Lee, S.S. & Lin, W.W. (2002) Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. Journal of Leukocyte Biology, 72, 207-216.
15. Jordan, C.T. (2002) Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia, 16, 559-562.
16. Kanamori, Y., Kigawa, J., Itamochi, H., Shimada, M., Takahashi, M., Kamazawa, S., Sato, S., Akeshima, R. & Terakawa, N. (2001) Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clinical Cancer Research, 7, 892-895.
17. Kelly, L.M., Kutok, J.L., Williams, I.R., Boulton, C.L., Amaral, S.M., Curley, D.P., Ley, T.J. & Gilliland, D.G. (2002) PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model. Proceedings of the National Academy of Sciences of the United States of America, 99, 8283-8288.
18. Keng, P.C. & Siemann, D.W. (1998) Measurement of proliferative activities in human tumor models: a comparison of four flow cytometric methods. Radiation Oncology Investigations, 6, 120-127.
19. Kusenda, J. (1998) Bcl-2 family proteins and leukemia. Neoplasms, 45, 117-122.
20. Lee, J.T. & McCubrey, J.A. (2002) The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia, 16, 486-507.
21. Majka, M., Ratajczak, J., Villaire, G., Kubiczek, K., Marquez, L.A., Janowska-Wieczorek, A. & Ratajczak, M.Z. (2002) Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Experimental Hematology, 30, 751-760.
22. Martelli, A.M., Tazzari, P.L., Tabellini, G., Bortul, R., Billi, A.M., Manzoli, L., Ruggeri, A., Conte, R. & Cocco, L. (2003) A new selective Akt pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia, 17, 1794-1805.
23. Milosevic, D. (2000) Potential diagnostic, prognostic and therapeutic implication of some new regulatory proteins in hematologic malignancies. Journal of Experimental and Clinical Cancer Research, 19, 175-181.
24. Min, Y.H., Eom, J.I., Cheong, J.W., Maeng, H.O., Kim, J.Y., Jeung, H.K., Lee, S.T., Lee, M.H., Hahn, J.S. & Ko, Y.W. (2003) Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia, 17, 995-997.
25. Neri, L.M., Borgatti, P., Tazzari, P.L., Bortul, R., Cappellini, A., Tabellini, G., Bellicosa, A., Capitani, S. & Martelli, A.M. (2003) The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Molecular Cancer Research, 1, 234-246.
26. Nicholson, K.M. & Anderson, N.G. (2002) The protein kinase B/Akt signaling pathway in human malignancy. Cellular Signalling, 14, 381-395.
27. Ringel, M.D., Hayre, N., Saito, J., Saunier, B., Schuppert, F., Burch, H., Bernet, V., Burman, K.D., Kohn, L.D. & Saji, M. (2001) Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Research, 61, 6105-6111.
28. Rowley, J.D. (1999) The role of chromosome translocations in leukemogenesis. Seminars in Hematology, 36, 59-72.
29. Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A. & Zauli, G. (2004) TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood, 103, 517-522.
30. Testa, J.R. & Bellacosa, A. (2001) AKT plays a central role in tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 98, 10983-10985.
31. Tse, K.F., Mukherjee, G. & Small, D. (2000) Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia, 14, 1766-1776.
32. Xu, Q., Simpson, S.E., Scialla, T.J., Bagg, A. & Carroll, M. (2003) Survival of acute myeloid leukaemia cells requires PI3K activation. Blood, 102, 972-980.
33. Yuan, Z.Q., Sun, M., Feldman, R.I., Wang, G., Ma, X., Jiang, C., Coppola, D., Nicosia, S.V. & Cheng, J.Q. (2000) Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene, 19, 2324-2330.
34. Zhao, S., Konopleva, M., Cabreira-Hansen, M., Xie, Z., Hu, W., Milella, M., Estrov, Z., Mills, G.B. & Andreeff, M. (2004) Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia, 18, 267-275.